Metraipolis › archive › dc_f666efbb5c87

Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus — Europe PMC PMID:41466278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41466278
DOI
10.1186/s12991-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-07T08:47:19.550Z
SHA-256 of the archived text
68fc7a97c53f6510fa8aea1df2797f1f0f30cde3eb36fac6b3804a518a5a6fc5
Stable URL of this page
https://metraipolis.com/documento/dc_f666efbb5c87

How to cite

Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus — Europe PMC PMID:41466278 — Europe PMC (en), https://europepmc.org/article/MED/41466278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f666efbb5c87 (Metraipolis archive dc_f666efbb5c87, sha256 68fc7a97c53f6510fa8aea1df2797f1f0f30cde3eb36fac6b3804a518a5a6fc5)
BibTeX
@misc{dcf666efbb5c87,
  title = {Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus — Europe PMC PMID:41466278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41466278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f666efbb5c87; sha256 68fc7a97c53f6510fa8aea1df2797f1f0f30cde3eb36fac6b3804a518a5a6fc5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41466278. Agents can read the archived copy with the MCP tool read_document.